Saol Therapeutics: Amneal acquires Saol Therapeutics Baclofen franchise
The Bridgewater-based company says the deal expands its commercial institutional and specialty portfolio in neurology, and adds commercial infrastructure in advance of its entry into the biosimilar institutional market. The post Amneal acquires Saol Therapeutics†Baclofen franchise appeared first on NJBIZ.
Read full article »
Saol Therapeutics is a Georgia-based pharmaceutical company that provides therapies for CNS disorders such as pain management, spasticity, and orphan diseases.
Read more